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Abstract
Background: Transmissible spongiform encephalopathy (TSE) diseases are known to be zoonotic diseases that can
infect different kinds of animals. The transmissibility of TSE, like that of other infectious diseases, shows marked
species barrier, either being unable to infect heterologous species or difficult to form transmission experimentally.
The similarity of the amino acid sequences of PrP among species is believed to be one of the elements in
controlling the transmission TSE interspecies. Other factors, such as prion strains and host’s microenvironment, may
also participate in the process.
Methods: Two mouse-adapted strains 139A and ME7 were cerebrally inoculated to Golden hamsters. Presences of
scrapie associate fibril (SAF) and PrP
Sc in brains of the infected animals were tested by TEM assays and Western blots
dynamically during the incubation periods. The pathogenic features of the novel prions in hamsters, including
electrophoretic patterns, glycosylating profiles, immunoreactivities, proteinase K-resistances and conformational stabilities
were comparatively evaluated. TSE-related neuropathological changes were assayed by histological examinations.
Results: After long incubation times, mouse-adapted agents 139A and ME7 induced experimental scrapie in
hamsters, respectively, showing obvious spongiform degeneration and PrP
Sc deposits in brains, especially in cortex
regions. SAF and PrP
Sc in brains were observed much earlier than the onset of clinical symptoms. The molecular
characteristics of the newly-formed PrP
Sc in hamsters, 139A-ha and ME7-ha, were obviously distinct from the
original mouse agents, however, greatly similar as that of a hamster-adapted scrapie strain 263 K. Although the
incubation times and main disease signs of the hamsters of 139A-ha and ME7-ha were different, the pathogenic
characteristics and neuropathological changes were highly similar.
Conclusions: This finding concludes that mouse-adapted agents 139A and ME7 change their pathogenic
characteristics during the transmission to hamsters. The novel prions in hamsters’ brains obtain new molecular
properties with hamster-specificity.
Background
Scrapie, a kind of transmissible neurodegenerative dis-
ease in sheep and goats described hundreds years ago,
possesses similar neuropathological features and mole-
cular properties as Creutzfeldt-Jakob disease (CJD) and
Kuru in human and bovine spongiform encephalopathy
(BSE) in cattle. Based on the incubation time, diseases
signs, neuropathological characteristics, distribution of
PrP
Sc in central nerve system, electrophoresis mobility
and glycosylation pattern, more than twenty strains of
scrapie have been described up to now [1]. Scrapie can
transmit horizontally among the sheep and goats, or
deliver to the lamb vertically [2]. The infectivity and
transmissibility of scrapie, CJD and BSE lead those dis-
orders to being nominated as transmissible spongiform
encephalopathies (TSE).
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ered as an abnormal protein without nucleic acid identi-
fied so far. The infectious protein, PrP
Sc, shares the
same amino acid sequence as its normal isoform that
distributes on the cellular membrane in several kinds
cells with GPI-anchor [3]. During the pathogenesis of
TSE, PrP
Sc may replicate itself, resulting in aggregation
to plaque and damage to neuron cells. Probably due to
the conformational changes, PrP
Sc acquires several parti-
cular features once it forms, i.e. insoluble in ordinary
degenerates, partially resistant to digestion of protease,
resistant to inactivity of UV, radial and commonly used
sterilization [4].
TSEs are widely considered as the zoonotic diseases,
which can transmit across different species. Historically,
the outbreaks of mink spongiform encephalopathy in
North America have been believed to be the infection of
scrapie from lamb [5]. The most famous example is the
outbreaks of BSE in cattle caused by feed of meat-and-
bone meal contaminated with scrapie agents, which
directly cause emergence of human variant CJD (vCJD)
and feline spongiform encephalopathies in cats later [6].
Up to now, more than 220 vCJD cases have been
described worldwide, bringing with a great concern in
public health. On the other hand, the transmissibility of
TSE, like that of other infectious diseases, shows mark-
edly species barrier, either being unable to infect hetero-
logous species, e.g. scrapie of sheep and chronic wasting
disease of deer to human, or difficult to form transmis-
sion experimentally [7]. It emphasizes again that prion
possesses similar general features in transmission across
species as other microorganisms, although it has unique
biological characteristics.
In the case of housekeeping genes, the genes encoding
PrP protein (PRNP) are conservative among species dur-
ing evolution. The mutations within PRNP are thought
to lead directly to disease without the requirement for
an exogenous infectious agent [8]. When an infectious
TSE agent transmits to a new host, a specie-barrier has
been repeatedly observed, although the mechanism of
susceptibility to host has not yet been clearly defined.
Polymorphism in PrP from a number of species is
thought to play a role in both the TSE host susceptibil-
ity and the control of incubation period [9]. The simila-
rities of the amino acid sequences of PrP among species
play essential roles in the transmission of prion diseases
across animal species. In fact, both naturally-occurred
and experimental TSEs show significant tendency to
induce the infection more easily onto the species closer
to the original one [10].
The emergence of additional novel mammalian prion
disease strains has been witnessed since the outbreak of
BSE. To get more detailed insight of the alterations of
prion disease strains characteristics through interspecies
transmission, we inoculated mouse-adapted scrapie
strains 139A and ME7 onto Golden hamsters. After dif-
ferent long incubation periods, the experimental TSEs
were observed in the inoculated hamsters. We found
that the newly-formed strains in hamsters (139A-ha and
ME7-ha) obtained new molecular and biochemical fea-
tures that were similar as that of the hamster-adapted
scrapie agent 263 K. Meanwhile, we confirmed again
that the appearances of scrapie-associated fibrils (SAF)
and proteinase K (PK) resistant PrP in brains infected
with agent 139A and ME7 were much earlier than the
emergence of clinical manifestations. This finding con-
cludes that mouse-adapted agent 139A and ME7 change
their pathogenic characteristics during cross-species
transmission in hamsters.
Results
Inoculations of mouse-adapted scrapie strains 139A and
ME7 into hamsters induced experimental TSE after long
incubation
Brain homogenates of C57 mice infected with mouse-
adapted scrapie strains 139A and ME7 were intracere-
brally inoculated into hamsters. Except three hamsters
in the group of agent 139A died suddenly in the first
week after inoculation, all other animals were alive. Ani-
mals infected with strain 139A showed the clinical man-
ifestations 385 to 405 days after inoculation, with the
average incubation of 395 ± 8.5 days (Figure 1). The
most predominant and observable symptoms of the
infected hamsters were itchy and scratchy in the later
stage, most animals having obvious skin claws. The clin-
ical courses from onset to death persisted from 25 to 30
days (Table 1). Animals infected with strain ME7
became ill 460 to 530 days after inoculation, with the
a v e r a g ei n c u b a t i o no f4 9 6 . 2 5±2 7 . 2 2d a y s( F i g u r e1 ) .
The clinical manifestations were severe thin and
Figure 1 Comparative incubation periods of the experimental
scrapie in hamsters cerebrally infected with the hamster-
adapted strain 263 K and mouse-adapted strains 139A and
ME7. The abscissa shows the survival days and the y-axis shows the
percentages of the survival.
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were 30 to 40 days (Table 1). It confirms again that the
mouse-adapted scrapie strains can overcome the species
barrier to infected hamsters.
SAFs and PrP
Sc were detected in brain tissues much
earlier than the onset of clinical manifestations
Previous study revealed that PrP
Sc and SAF appeared
almost simultaneously in brains of the hamsters infected
with scrapie 263 K earlier than the onset of clinical symp-
toms [11]. To see the possible appearances in the ham-
sters’ brains infected with scrapie agents 139A and ME7
during incubation period, one animal from each group
was randomly selected and the brain was removed surgi-
cally 200 days after inoculation, with interval of 20 days
till the onset of clinical manifestations. In line with the
observation of agent 263 K-infected hamsters, both SAFs
and PrP
Sc were detected in the brain tissues earlier than
the appearance of clinical symptoms. Interestingly, SAFs
were observed in brain tissues much earlier than PrP
Sc,
that in the group of agent 139A, SAF was firstly detected
in the hamster 224 days, while PrP
Sc in the 286 days after
inoculation (Table 2), andi nt h eg r o u po fa g e n tM E 7 ,
SAF was firstly detected in the animal 250 days, while
PrP
Sc in the 330 days after inoculation (Table 3). Both
PrP
Sc and SAF were persistently observed in the follow-
ing tested animals. It indicates that prion-related events,
especially SAF, appear much earlier than the onset of
clinical manifestations.
SAFs of three scrapie strains in hamsters’ brains showed
the similar morphological structures
Screening more than 5 brain samples of each three
strains at the terminal clinical stage identified many
long, ramose and roughly 25 nm in diameter fibrils,
whose surfaces were shaggy (Figure 2). Compared with
the observations of brains infected with agents 263 K
(Figure 2A), the amounts of SAFs in 139A-ha (2B) and
ME7-ha (2 C) infected hamsters seemed to be smaller,
while the SAFs in the ME7-infected brains were rela-
tively shorter. To address the major components of
SAFs, brain homogenates were incubated with mAb 3
F4 and subsequently with SPA-coupled gold. EM assays
showed large amounts of fibrils covered with black dots
(Figure 2D) in the brain homogenates infected with
agent 263 K, suggesting that PrP are the main elements
of fibrils.
Similar pathological changes in the brain cortex of the
three scrapie strains in hamsters but comparatively
severe in the 263 K strain
To see the neuropathological characteristics caused by
infections with the three scrapie strains in hamsters, his-
topathological analyses were comparatively performed
on the regions of cortex and cerebellum. Spongiform
degeneration was more intensive and severe in the cor-
tex infected by strain 263 K, featured with many
vacuoles distributed in the field of vision, while moder-
ate spongiform degeneration was observed in the cortex
infected by strains 139A and ME7 (Figure 3A, upper
panels). The lesion scores of in the cortex regions of
strains 263 K, 139A-ha and ME7-ha were evaluated as
4, 2.0 and 2.5, respectively (Figure 3B). Contrast to the
changes in the cortex regions, typical spongiform was
rarely observed in cerebellum regions of all three strains
(Figure 3A, middle panels). Furthermore, gliosis in brain
cortex regions were tested by IHC with a commercial
mAb against GFAP. Abundant large GFAP-positively
stained astrocytes were detected, in which the gliosis in
the agent ME7-ha infected brains were comparably
severe as that in agent 263 K-infected one, while gliosis
in the agent 139A-ha infected brains was significantly
mild (Figure 3A, lower panels).
The PrP
Sc molecules of 139A- and ME7-infected hamsters
changed their electrophorestic profiles compared with
those of their parent mouse-adapted strains
Presences of PrP
Sc in brain homogenates of the ham-
sters infected with strains 139A and ME7 at the term-
inal stage of diseases were tested by Western blot assays
with PrP specific monoclonal antibody 3 F4 after PK
treatment. Protease resistant bands (PrP
res) were seen in
all diseased animals, which mobilized roughly at 19-25
kDa. Interestingly, the PrP
res from the brains infected
with strains 139A and ME7 showed identical electro-
phoretic and glycosylation profiles, in which the diglyco-
syl form of PrP
res was the most predominant, followed
by monoglycosyl and nonglycosyl forms, showing similar
Table 1 Comparison of the incubation period, clinical
course and main clinical manifestations of the infected
hamsters inoculated with three scrapie strains
Strain Incubation (days) Clinical
course (days)
Clinical
manifestation
263 K* 66.7 ± 11 (45-72) 5-7 ataxia
139A 395 ± 8.5 (385-405) 25-30 scratch
ME7 496.25 ± 27.22 (460-530) 30-40 severe thin, sluggish
*referring to [11]
Table 2 Dynamic analyses of SAF and PrP
Sc in the brain
tissues of the hamsters infected with scrapie strain 139A
Days after
inoculation
200 224 245 264 286 307 328 357 385-405
No. of animals 111111115
S A F - ++++++++
PrP
Sc ----+ + + + +
Clinical signs --------+
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Sc in the brain tissues of the hamsters infected with scrapie strain ME7
Days after inoculation 210 230 250 270 290 310 330 350 370 390 460-530
No. of animals 11111111116
S A F - - +++++++++
PrP
Sc ------+ + + + +
Clinical signs ----------+
Figure 2 Morphological assays of SAFs in the hamsters’ brains of three different scrapie strains in TEM. (A) agent 263 K. (B) agent 139A-
ha. (C) agent ME7-ha. (D) SAF in the brain homogenates infected with agent 263 K stained by immune colloidal gold technique with PrP
specific mAb 3 F4.
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infected with strain 263 K (Figure 4A). Calculating the
relative gray values of each glycosyl PrP
Sc bands in the
reactions with mAb 3 F4 showed that the percentages of
diglycosyl, monoglycosyl and nonglycosyl forms in the
brains of agent 263 K were 56.8%, 27.9%, 15.3%, the
forms of 139A-ha were 52.8%, 32.8%, 14.4% and the
forms of ME7-ha were 52.1%, 33.1%, 14.8%. Compared
with PrP
res in the mice brains infected by the individual
parent mouse-adapted strains in Western blot with PrP-
specific mAb 1E4, in which the monoglycosyl PrP
res
were predominant (Figure 4B), the diglycosyl PrP
res in
Figure 3 Neuropathological assays of the regions of cortex and cerebellum from the hamsters infected with agent 263 K, 139A-ha
and ME7-ha. (A) Top and middle panels are HE stains of cortex and cerebellum. Bottom panels are GFAP IHC stains of cortex. The arrows show
typical vacuoles. (B) Scores the severity and distribution of vacuolation. The average value for each brain region is calculated from three
independent counts and indicated as mean ± SD.
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nant (Figure 4A), suggesting that mouse-adapted scrapie
strains may change their PrP
Sc molecular profiles after
replicating in hamsters brains.
To get more information of PrP
res profiles, same
amounts of hamsters’ brain homogenates infected with
three different scrapie agents at the terminal stage of
diseases were comparatively assayed by Western blots
with other commercial PrP-specific mAbs, including
1E4, 6D11, 6H4 and 8H4. Like that in the reactions
with mAb 3 F4, similar electrophoretic and glycosylated
PrP
res patterns were observed in the preparations
reacted with the tested antibodies, all showing predomi-
nately diglycosal PrP
res (Figure 4D). In line with the
observations in Figure 4A reacted with mAb 3 F4, clear
small molecule-weight bands at the position of Mr 21
were detected in all three homogenates in the reaction
with mAb 6D11, indicating presences of the truncated
C2 fragments (Figure 4D). Additionally, at our experi-
mental condition, relatively weaker signals of PrP
res
were observed in 139A infected hamsters’ brains in the
Western blots with various PrP mAbs.
The PrP
Sc of the three scrapie strains in hamsters had the
similar PK-resistance
To test the PK-resistances of PrP
Sc from the three scra-
pie strains, brain homogenates from 3 infected animals
at the terminal stage of diseases were pooled as the
representative samples and exposed to the digestion
with different amounts of PK from 20 to 1000 μg/ml.
The input PrP amounts in various homogenates were
equilibrated by Western blots prior to PK-treatment.
Figure 5A revealed PrP
res signals in all preparations at
the experimental condition. Compared with the input
PrP, the intensities of PrP
res signals of the three scrapie
strains in the preparations of 20 μg/ml PK decreased
slightly. The PrP
res signals of scrapie agents 263 K and
ME7 remained fairly stable in the reactions containing
20 to 1000 μg/ml PK, but that of agent 139A started to
drop down from the preparation of 200 μg/ml PK
(Figure 5B). These results indicate that the PrP
Sc in
hamsters’ brains by infections of hamster-adapted agent
263 K or mouse-adapted agents 139A and ME7 have
similar PK-resistant features.
The PrP
Sc of the three scrapie strains in hamsters had
similar conformational stability
Exposure of PrP
Sc to increasing concentrations of
GdnHCl leads to a transition from the native to dena-
tured state, measured as loss of resistance to protease
digestion. To test the consistency of three kinds of PrP
Sc
Figure 4 Analyses for PrP
Sc in brain homogenates with Western
blots. (A) PrP
Sc in hamsters’ brains of agent 263 K, 139A and ME7
detected with mAb 3 F4. (B) PrP
Sc in mice brains of agent 139A and
ME7 detected with mAb 1E4. (C) Deglycosylated PrP
Sc in hamsters’
brains of agent 263 K, 139A and ME7 detected with mAb 3 F4. (D)
Immunoreactivities of PrP
Sc in hamsters’ brains of agent 263 K, 139A
and ME7 with a panel of PrP specific mAbs, including 1E4, 6D11, 3 F4,
6H4 and 8H4. Molecular weight standards are shown on the left and
different mAbs are shown on the right. “+": with PK or PNGase F; “-":
without PK The products of PK-digested PrP
Sc from the hamsters’
brains infected by mouse-adapted agents 139A and ME7 were
further exposed to glycosidase. One single PrP-specific bands were
observed, which were at the exactly same position in SDS-PAGE as
that in the preparation of 263 K PrP
Sc (Figure 4C). It implies that the
newly-formed PrP
Sc in the hamsters’ brains by infections of mouse-
adapted scrapie agents have the same glycosylated profiles as the
hamster-adapted scrapie strain 263 K.
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representative samples of these three infected hamsters
were incubated with a series of amounts of GdnHCl
from 1 to 6 M separately. The input PrP amounts in
various homogenates were equilibrated by Western blots
prior to GdnHCl- treatment. Western blots with mAb 3
F4 revealed that the total PrP signals from preparations
of the agent 263 K remained comparatively constant
among the reactions with different concentrations of
GdnHCl while PrP signals of the agents 139A-ha and
ME7-ha weakened clearly only in the reactions of 6 M
GdnHCl (Figure 6A and 6B). The GdnHCl-treated pro-
ducts were subsequently exposed to the proteolysis with
50 μg/ml PK. PrP
res signals were detectable in
Figure 5 PK resistance of PrP
Sc in hamsters’ brains of agent 263 K, 139A-ha and ME7-ha. (A) Western blots with mAb 3 F4. The
concentrations of PK in individual preparation are indicated on the top. Molecular weight standards are shown on the left. (B) Quantitative
analyses of each gray numerical value of PrP blots. Relative gray values of the PrP signals in each experiment are normalized by division with
that of the respective reaction without PK. The average values are calculated from three independent blots and presented with as mean ± SD.
Figure 6 Conformational stability of PrP
Sc in hamsters’ brains of agent 263 K, 139A-ha and ME7-ha. (A) Western blots of total PrP with
mAb 3 F4. Hamsters’ brain homogenates are incubated with 1 to 6 M GdnHCl. The concentrations of GdnHCl in individual preparation are
indicated on the top. Molecular weight standards are shown on the left. (B) Quantitative analyses of each gray numerical value of total PrP blots.
The average values are calculated from three independent blots and presented with as mean ± SD. (C) Western blots of PrP
Sc with mAb 3F4.
Hamsters’ brain homogenates are incubated with 1 to 6 M GdnHCl and subsequently exposed to 50 μg/ml PK. The concentrations of GdnHCl in
individual preparation are indicated on the top. Molecular weight standards are shown on the left. (D) Quantitative analyses of each gray
numerical value of PrP
Sc blots. The average values are calculated from three independent blots and presented with as mean ± SD.
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bated with GdnHCl below 4 M and in that of the agent
263 K incubated with GdnHCl below 5 M (Figure 6C).
Calculations of the relative gray values of PrP
res signals
showed that PrP
Sc in the preparations of agents 139A-
ha and ME7-ha started to drop down remarkably after
exposed with 3 M GdnHCl and disappeared since 4 M
GdnHCl, whereas PrP
Sc of agent 263 K became notable
weak after exposed with 4 M GdnHCl and undetectable
since 5 M GdnHCl (Figure 6D). These data indicate that
the mouse-adapted scrapie strains 139A- and ME7-
induced PrP
Sc in the brains of hamsters have the similar
conformational stabilities as that of the agent 263 K-
induced PrP
Sc.
To see the potential influences of GdnHCl on the
morphology of SAFs, brain homogenates of 263 K,
139A-ha and ME7-ha-infected hamsters were individu-
ally incubated with 3 M GdnHCl. EM assays identified
the clusters of small round particles and short clubs
stained by phosphomolybdic acid in the three scrapie
s t r a i n s( F i g u r e7 ) .N oS A F - l i k es t r u c t u r e sw i t hl o n g ,
ramose or straight fibrils were observed after exposing
to GdnHCl.
Discussion
In this study, we have set up two experimental scrapie
infections on hamsters by cerebral inoculations of
mouse-adapted scrapie agent 139A and ME7. Typical
neuropathological abnormalities of TSE and deposits of
PrP
Sc have been observed in the brains of the infected
hamsters, confirming again that mouse-adapted scrapie
agent can overcome species barrier to infect hamsters.
The PrP proteins of mouse and hamster share a great
deal of homology in amino acids sequences and in ter-
tiary structures, with only seven amino acids differences.
Our data here provide the evidences that hamster’s PrP
C
supplies as the substrate for replication of mouse-
derived PrP
Sc. A number of sCJD strains can transmit
more efficiently to the human PrP transgenic mouse
lines than to wild type mice, which shows shorter
incubation times and higher susceptibility [12]. How-
ever, it makes an exception that replacement of the
murine PrP gene with bovine PrP gene led surprisingly
to longer incubation period for BSE in the transgenic
mice than in the wild type mice despite the increase in
identity between the host and donor PrP [13]. It seems
that except for the consistence of PRNP sequences,
other unknown factors will affect on the host suscept-
ibility. Like other TSE transmissions among different
species [14], the clinical manifestations in the infected
hamsters emerge extremely late after long incubation
times. It reflects an inefficient conversion from ham-
ster’sP r P
C to PrP
Sc by exotic mouse prion protein dur-
ing the first passage. Successive passages of the new
strains in hamsters in future may decrease and fix the
respective incubation periods.
Different incubation times and clinical courses in
hamsters by infection of agents 139A and ME7 imply
that besides the amino acid homology between mouse
and hamster, scrapie strain is another element for the
transmission across species. Such phenomena have been
described elsewhere [15]. The amounts of the infectious
agents in this study seem not to be the essential reason,
since the levels of PrP
Sc of two strains, regardless in
mice brains as the inoculum or in hamster brains as the
product, are quite comparable. One speculation may lie
on the differences in their unknown tertiary structures
of those two prion strains, leading to the differences
possibly in molecular level during conversion from PrP
C
to PrP
Sc.
The hamsters infected with mouse-scrapie agent 139A
and ME7 possess similar pathogenic and pathological
changes. Instead of the predominantly monoglycosyl
PrP
res in the original mouse-adapted strains, the PrP
res
formed in the hamster brains infected with agents 139A
and ME7 are predominant diglycosylated, which show
the same glycosylation patterns as that of a hamster-
adapted scrapie strain 263 K. Apart from the glycosylat-
ing profiles of PrP
Sc, other main biochemical features of
the two newly-formed PrP
Sc in hamsters, i.e.
Figure 7 Morphological assays of SAFs in the hamsters’ brains of three different scrapie strains after incubated with 3 M GdnHCl. (A)
agent 263 K; (B) agent 139A-ha; (C) agent ME7-ha.
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in GdnHCl, are highly comparable with that of agent 263
K. Those data indicate that two kinds of the newly-
formed PrP
Sc in hamster brains lose their original mole-
cular characteristics in mouse brains, while obtain new
properties that show markedly hamster-specific.
Our data emphasize the host microenvironment
affects obviously the molecular features of the new
PrP
Sc generated during transmission across species.
Other previous studies have shown that TSE strains
alter their characteristics during the passage in a foreign
species and the changed features maintained stably with
the serial passage, besides the latent period became
shorter than the first passage [16,17]. It is belived that
inter-species prion disease transmission is frequently the
acquisition of new strain properties, in which transgenic
mouse and protein misfolding cyclic amplification
(PMCA) approaches provide a facile means of generat-
ing and characterizing novel prion strains [18]. However,
some kinds of prion strains never sacrifice the original
molecular properties when infecting onto other species.
The famous example is BSE agent, which keeps its main
biochemical and molecular characteristics after causing
infection on human (vCJD), cats (FSE) and other ungu-
lates (exotic ungulate encephalopathy) [19]. The exact
reason for such difference among prion strains remains
unclear. It is speculated that interactions with chaper-
ones or other cellular factors, depending on prion var-
iant, will be at least part of some species barriers [20].
Nevertheless, this mysterious phenomenon lies at least
on prion strain, host PrP
C and host microenvironment.
During the course of TSE, a kind of protein fibril,
referred as SAF, is usually observed in brain tissues [21].
SAFs are abnormal structures uniquely associated with
prion diseases of many species. The major, even exclu-
sive component for SAF is PrP
Sc [22]. The structure of
SAF in vitro can be destroyed easily by many physical
and chemical agents, including GdnHCl in this study.
Although it is still not settled whether the infection of
prion needs a fixed morphological structure like virus, it
is certain that maintenance of SAF in inoculum is not
indispensable. Our previous study [23] and others [24]
have repeatedly addressed GdnHCl-treated brain
extracts from scrapie infected animals, in which the
fibriform structures of SAFs are undetectable, still main-
tain its infectivity. Unfortunately, the SAF structures of
the original mouse-adapted strains 139A and ME7 are
hard to be observed, possibly because of long-term
stored specimen. Comparison of the SAF structures of
the one TSE agent from different infected species will
help to understand the potential ultra-structural changes
in during interspecies transmission.
One of the features of prion diseases is that they
usually have extremely long incubation. In line with the
results of our previous study of the experimental bioas-
says on hamsters with scrapie agent 263 K [11], SAF
and PrP
Sc have been observed in brains infected with
agent 139A and ME7 during their incubation periods,
which are much earlier than the appearance of clinical
symptoms. Those accord well with the natural phenom-
enon of almost all infectious diseases that the pathogens
are usually detectable earlier than the appearance of
clinical symptom. Interestingly, SAFs are observed much
earlier than the PrP
Sc in the brain tissues from the two
infections in our experimental condition. Whether it is a
general feature for TSEs is not known. If it were, it
would highlight that the nascent constructs of PrP
Sc in
the early stage of disease may not be stable enough for
resisting the routinely concentrated PK digestion. Never-
theless, our data stress again that assays for SAF and
PrP
Sc in brains are useful biomarkers for screening TSE
before onset of symptoms.
Conformational stability of PrP
res has also been used
to differentiate TSE strains. When PrP
C converts to
PrP
Sc, the increased component of b-sheet structure
makes the prion protein more stable to resist the effec-
tiveness of GdnHCl and PK [25]. According to our data,
the resistibility of the three hamster-adapted scrapie
strains to GdnHCl and PK is almost similar, though
strain 139A-ha is slightly weak. This similarity elucidates
that a consistency of PrP
res form in hamsters in the
molecular level.
Methods
Animal bioassay
Brain materials from hamster scrapie strain 263 K,
mouse scrapie strains 139A and ME7 were homogenized
(1:10) prior to challenging as inoculum. 1 μl of indivi-
dual brain homogenate was intracerebrally injected into
15-day old Golden hamsters under halothane anaesthe-
sia respectively. Each group consisted of 16 hamsters.
For equilibrating the injected amounts of the different
strains, we analyzed the absolute PrP
Sc grey value of dif-
ferent strains by Western blot method with the same
loading volume after totally PK digestion. The clinical
symptoms and signs were scored as described previously
[11] and the incubation was calculated from the inocula-
tion to the terminal stage of the disease individually.
Then the animals were euthanized at the end of clinical
phase and brains were taken surgically for further stu-
dies during the incubation period and after the onset of
illness.
Transmission electron microscopy (TEM) assays
The individual brain homogenate of hamster scrapie
strain 263 K, hamster scrapie strains 139A and ME7
were absorbed onto copper nets covered with carbon
membrane and stained with 2% phosphomolybdic acid
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(SAF) was observed with transmitted electron micro-
scopy at the condition of 80 KV (Philips, JEOL1200EX).
For colloidal gold immunoelectron microscopy assays,
samples were absorbed onto copper nets and incubated
w i t h1 : 1 0 0d i l u t e dm A b3F 4f o r8h r .A f t e rw a s h e d
with PBS for three times, the copper nets were exposed
to 1:50 diluted 5 nm SPA-immunogold for 1 hr and
stained with 2% phosphomolybdic acid as described
above.
Pathological assays
Brain tissues of different hamster-adapted strains were
fixed in 10% buffered formalin solution. Before histolo-
gical processes, all the fixed tissues were immersed in
98% formic acid for at least 1 h for inactivation. Paraffin
sections (5 μm in thickness) were subjected to conven-
tional staining with hematoxylin and eosin (HE). The
spongiform degeneration for the three strains was moni-
tored by light-microscopy and the severity and distribu-
tion of vacuolation were measured according to the
protocol described elsewhere [26], briefly, 0, no lesions;
0.5, minimum vacuolation (2-3 vacuoles in half a × 40
objective field); 1.0, little vacuolation (3-5 vacuoles in
half a field); 2.0, moderate vacuolation (several vacuoles
evenly scattered); 3.0, extensive vacuolation (many
vacuoles distributed in half a field); 4.0, severe vacuola-
tion (numerous vacuoles often coalescing). For glial
fibrillary acidic protein (GFAP), the sections were incu-
bated with 1:500 diluted anti-GFAP mAb at 4°C over-
night. Subsequently, the goat anti-mouse IgG
biotinylated antibody diluted 1/200 in 10% normal goat
serum was incubated for 30 min at room temperature,
and an avidin-biotin-peroxidase complex was applied
using diaminobenzidine (DAB) as a substrate. Finally,
sections were counterstained with hematoxylin for 1
min, dehy-drated, and routinely mounted [11].
Purification of PrP
Sc and proteinase K (PK) digestion
The brain samples of the infected hamsters and mice
were homogenized in 10% lysis buffer (100 mM NaCl,
10 mM EDTA, 0.5% Nonidet P-40, 0.5% sodium deoxy-
cholate, 10 mM Tris, pH 7.5) according to the protocol
described elsewhere [27]. PrP
Sc-enriched fractions of
brain homogenate prepared from the different strains
were centrifuged at 1000 rpm for 10 min and the cell
debris was removed. The supernatants were collected
and centrifuged at 20 000 g for 90 min, and the pellets
were treated again as above. Then the pellets were
mixed and stored at -80°C as the purified insoluble
PrP
Sc.
The brain homogenates from three biological samples
of each strain collected at the terminal stage were
pooled as the representative samples of individual
strains. For detection of PK-resistant PrP (PrP
res)i n
brain tissues, the samples were incubated with 50 μg/ml
of PK (Merck) at 37°C for 60 min. For evaluation of PK-
resistances of PrP
Sc from various hamster-adapted
strains, the brain specimens were treated with different
amounts of PK at the final concentrations of 20, 50,
100, 200, 500 and 1000 μg/ml at 37°C for 60 min. The
digestions were stopped with 3 mM PMSF (Sigma) for
Western blot. Different strain samples were undergone
with 3 separate PK treatments.
Western blots
Samples were separated in 12% SDS-PAGE and electro-
nically transferred to a nitrocellulose membrane accord-
ing to the protocol described elsewhere [28]. For the
mouse-derived specimen, PrP-specific monoclonal anti-
body (mAb) 1E4 (dilution 1:1000) was used as the pri-
mary antibody. For the hamster-derived samples, PrP-
specific mAb 1E4, 6D11, 3 F4, 6H4 and 8H4 (dilution
1:1000) were used respectively. The reactions were con-
ducted in TBS-T (10 mM Tris-HCl, pH 7.8, 100 mM
NaCl, 0.05% Tween 20) containing 5% (wt/vol) nonfat
milk at 4°C overnight and subsequently washed three
times with TBS-T. Then the membranes were incubated
with horseradish peroxidase-conjugated (HRP)-conju-
gated goat anti-mouse immunoglobulin G (Santa Cruz)
at 37°C for 1 h and PrP-specific signals was detected
with an ECL detection kit (Amersham-Pharmacia
Biotech).
Deglycosylation assay
After mixed with equal volume of glycoprotein denatur-
ing buffer (New England Biolabs), various PrP
Sc prepara-
tions were heated at 100°C for 10 min. Subsequently, 50
mM sodium phosphate, pH 7.5, containing 1% NP-40
and 2 μl of N-glycosidase F (1,800,000 U/mg, New Eng-
land Biolabs) were added into the samples and the mix-
tures were incubated at 37°C for 2 h. PrP signals in each
preparation were detected by Western blot as described
above.
Conformational stability assay
100 μl of the representative sample each strain men-
tioned above were mixed with five volumes of cold
methanol at -20°C for 2 h. After centrifuged at 20 000 g
for 30 min, the pellets were resuspended with 100 μlo f
different concentration of GdnHCl, including 1, 2, 3, 4,
5 and 6 M and incubated at 37°C for 12 h as described
elsewhere [29]. Subsequently, five volumes of cold
methanol was added into each preparation and main-
tained at -20°C for 2 h. After centrifuged at 20 000 g for
30 min, the pellet was resuspended with 100 μlT Nb u f -
fer (10 mM Tris, 130 mM NaCl, pH 7.0). Half part was
employed directly into SDS-PAGE and the rest was
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Different strain samples were undergone with 3 separate
GdnHCl and PK treatments.
Quantitative and statistical analysis
Quantitative analysis of immunoblot images was carried
out using computer-assisted software Image Total Tech
(Pharmacia). Briefly, the image of immunoblot was
scanned with Typhoon (Pharmacia) and digitalized,
saved as TIF format. The values of each target blot were
evaluated. All data are presented as the mean ± SD.
Conclusions
The paper concludes that mouse-adapted agent 139A
and ME7 change their pathogenic characteristics during
interspecies transmission on hamsters. The novel prion
strains formed in hamsters’ brains obtain new molecular
properties with hamster-specificity.
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